Search

EHA-ASH TRTH Joint Oversight Committee

Current committee members
John Crispino, USA (ASH Co-Director)
Shai Izraeli, Israel (EHA Co-Director)
Jose Lopez, USA (ASH Incoming Co-Director)
Jose Ignacio (Iñaki) Martin-Subrero, Spain (EHA Incoming Co-Director)
Alisa Wolberg, USA (ASH Executive Member)
Chiara Bonini, Italy (EHA Executive Member)
AimTo develop, in collaboration with ASH, translational researchers…

Read more

Restrictions

EHA is guided by the concept of supporting as many young investigators/clinicians as possible in their career development. Therefore, double awarding is not allowed.

Read more

EHA Issues Recommendations on Mild to Moderate Bleeding Disorders

HemaSphere presents first in a series of Consensus Reports on Diagnosis of Inherited Bleeding Problems

For hematologists, it can be challenging to make the correct diagnosis in patients with bleeding problems – or even to determine whether there is any bleeding…

Read more

EHA-AAH Balkan Hematology Tutorial 2022

EHA is joined forces with the Albanian Association of Hematology (AAH) to organize the EHA-AAH Balkan Hematology Tutorial.

Read more

EHA Guidelines by Topic

AL Amyloidosis
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines (2021)
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group (2022)
Bleeding and thrombosis
EHA Guidelines on management of antithrombotic treatments…

Read more

EU pilot on drug repurposing

Drug repurposing (finding new indications for existing authorized medicines) is increasingly prominent in the debate about improving access to medicines. As stated in EHA’s position paper on access to affordable orphan medicines (Merlini et al.

Read more